Please login to the form below
Qsiva
This page shows the latest Qsiva news and features for those working in and with pharma, biotech and healthcare.
Eisai doubles Belviq's US sales force
This followed a knockback for Vivus' drug in October 2012, when regulators refused Qsiva (Vivus' preferred brand name for Europe) due to cardiovascular safety concerns.
Latest news
-
Orexigen files obesity drug in EU
In October 2012, Vivus faced a knockback from the European Medicines Agency (EMA) for obesity treatment Qsiva (phentermine/topiramate ER), despite receiving prior approval in the US. ... Like its rival Qsiva, Belviq is also recommended in the US.
-
Novo Nordisk on track to file liraglutide in obesity
There is still a long way to go before liraglutide reaches the market, however, and Novo should expect a tough regulatory challenge if the fate of recent obesity treatments Qsymia/ Qsiva
-
CHMP upholds rejection of Vivus' obesity drug
Still no recommendation for Qsiva in Europe. Vivus faced a major setback yesterday when a European Medicines Agency (EMA) committee upheld its earlier decision to reject the company's obesity drug ... has retained its position and said a cardiovascular
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Senior Account Manager
-
Competitive
-
Healthcare Account Director
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- COVID-19 vaccine developers respond to new strain
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- bluebird bio to separate oncology and rare diseases units
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
